Sodra Sandby, Sweden

Paul Andersson

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1997-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Paul Andersson: Innovator in Anti-Inflammatory Steroids

Introduction

Paul Andersson is a notable inventor based in Sodra Sandby, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the production of anti-inflammatory steroids. With a total of 2 patents, his work has had a meaningful impact on medical treatments for inflammatory and allergic conditions.

Latest Patents

Andersson's latest patents include innovative processes for the production of anti-inflammatory steroids. These processes involve acetalization, transacetalization, hydrolysis of an ester, or hydrogenation of a diene using appropriate starting materials. Additionally, he has disclosed pharmaceutical compositions that comprise the compounds produced by these processes, along with methods for treating inflammatory and allergic conditions using these compounds. Another area of his research includes fluorinated steroids, which further showcases his expertise in steroid chemistry.

Career Highlights

Throughout his career, Paul Andersson has been associated with Astra Aktiebolag, a prominent company in the pharmaceutical industry. His work has not only advanced the understanding of steroid production but has also contributed to the development of effective treatments for various medical conditions.

Collaborations

Andersson has collaborated with esteemed colleagues such as Bengt I Axelsson and Ralph Lennart Brattsand. These partnerships have enhanced the scope and impact of his research, leading to innovative solutions in the pharmaceutical field.

Conclusion

In summary, Paul Andersson is a distinguished inventor whose work in the production of anti-inflammatory steroids has made a significant impact on medical treatments. His contributions continue to influence the pharmaceutical industry and improve patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…